NCT06308276

Brief Summary

The randomized clinical trial (RCT) endeavors to enroll 50 participants, divided equally into aerobic exercise and resistance exercise groups. The study employs rigorous tools such as blood pressure measurement, SF-36 questionnaire, and the Six-Minute Walk Test (6MWT) to assess VO2max.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 4, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 13, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2024

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2024

Completed
Last Updated

July 23, 2024

Status Verified

July 1, 2024

Enrollment Period

3 months

First QC Date

March 4, 2024

Last Update Submit

July 22, 2024

Conditions

Keywords

Aerobic ExerciseAngioplastyObese PatientsPercutaneous Coronary InterventionResistance Training

Outcome Measures

Primary Outcomes (3)

  • Blood Pressure

    Blood pressure is a crucial physiological parameter often employed as a data collection tool in research, particularly in studies focused on cardiovascular health and related interventions.

    4 Weeks

  • Six Minute Walk Test

    The 6-minute walk test (6MWT) serves as a valuable and widely used data collection tool in research, particularly in studies assessing functional capacity, exercise tolerance, and overall physical performance.

    4 Weeks

  • SF 36 Questionnaire

    The Short Form 36 (SF-36) is a widely used health-related quality of life (HRQoL) questionnaire that serves as a comprehensive data collection tool in research studies across various disciplines.

    4 Weeks

Study Arms (2)

Group A

ACTIVE COMPARATOR

Brisk walking, jogging, cycling, or low-impact aerobics

Other: Aerobic Training

Group B

ACTIVE COMPARATOR

Full body resistance exercise targeting major muscle groups, including squats, lunges, chest presses, rows, and core exercises

Other: Resistance Training

Interventions

Aerobic Training: Brisk walking, jogging, cycling, or low-impact aerobics

Group A

Resistance Training: Full body resistance exercise targeting major muscle groups, including squats, lunges, chest presses, rows, and core exercises

Group B

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age: Participants must be between 40 and 60 years old.
  • Gender: Male and female both.
  • Cardiovascular Status: Post Percutaneous Coronary Intervention (PCI) patients with a documented history of coronary artery disease
  • Participants who are at least three months post PCI to ensure stabilization of their cardiovascular condition.
  • Obesity: Participants must have a Body Mass Index (BMI) equal to or greater than 30 kg/m², indicating obesity.
  • Health Status: Participants should be in stable health condition to participate in moderate physical activities.
  • Willingness to Participate: Participants must provide informed consent and be willing to comply with the study protocol, including attending scheduled exercise sessions and follow-up assessments.
  • Participants capable of engaging in either aerobic or resistance training, were assessed by a physical activity readiness questionnaire (PAR-Q).

You may not qualify if:

  • Participants with severe physical limitations, disabilities, or musculoskeletal disorders that would prevent them from engaging in aerobic and resistance exercises.
  • Individuals with a history of substance abuse or current substance abuse issues that might interfere with their ability to participate or adhere to the study protocol.
  • Patients with Neurological diseases
  • Patients with severe or unstable heart conditions, recent heart attack, or heart failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sialkot Medical and Physiotherapy Center

Sialkot, Punjab Province, 51310, Pakistan

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Resistance Training

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Muhammad Faizan Hamid, MS-CPPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Clinical Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2024

First Posted

March 13, 2024

Study Start

March 1, 2024

Primary Completion

June 5, 2024

Study Completion

June 15, 2024

Last Updated

July 23, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations